MediPal Holdings Corporation
Stock Price Chart
2026/08/23 UpdatedPrice Trend
2026/08/23 UpdatedPrice & Trading Details
2026/08/23 UpdatedPRICE
TRADING
Analyst Recommendations 4 analysts
Updated 2026/08/01Earnings Calendar
Updated 2026/08/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2026/05/14 | ¥38.24 | ¥25.19 | -34.1% |
| 2026/02/09 | ¥50.07 | ¥74.68 | +49.2% |
| 2025/11/04 | ¥44.32 | ¥60.63 | +36.8% |
| 2025/08/05 | ¥42.51 | ¥46.17 | +8.6% |
Shareholder Composition
Updated 2026/08/01Major Holders
Updated 2026/08/01| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
Columbia Funds Series Trust-Columbia Overseas Value Fund
|
2.8M | +4.48% | |
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
2.7M | -0.56% | |
|
Datum One Series Trust-BRANDES INTERNATIONAL SMALL CAP EQUITY FUND
|
2.1M | +6.94% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
1.8M | +1.30% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
1.3M | 0.00% | |
|
Fidelity Salem Street TRT-Fidelity SAI Intl Low Volatility Index Fd.
|
1.0M | +3.18% |
Dividend History
Updated 2026/08/23| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥34 | -46.9% |
| 2025 | ¥64 | +6.7% |
| 2024 | ¥60 | +13.2% |
| 2023 | ¥53 | +15.2% |
| 2022 | ¥46 | - |
Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥3,290,921M | ¥3,360,008M | ¥3,558,732M | ¥3,671,328M |
| Gross Profit | ¥217,445M | ¥224,304M | ¥246,654M | ¥255,758M |
| Operating Income | ¥45,627M | ¥48,976M | ¥47,334M | ¥55,613M |
| Pretax Income | ¥57,300M | ¥70,095M | ¥74,749M | ¥76,741M |
| Net Income | ¥29,423M | ¥38,806M | ¥41,474M | ¥40,279M |
| EPS | ¥131.41 | ¥179.12 | ¥195.83 | ¥193.20 |
| Operating Margin | 1.39% | 1.46% | 1.33% | 1.51% |
| Balance Sheet | ||||
| Total Assets | ¥1,709,474M | ¥1,709,658M | ¥1,799,127M | ¥1,824,984M |
| Total Equity | ¥530,301M | ¥561,357M | ¥600,349M | ¥619,564M |
| Total Liabilities | ¥1,179,173M | ¥1,148,301M | ¥1,198,778M | ¥1,205,420M |
| Cash | ¥243,150M | ¥195,031M | ¥230,154M | ¥261,407M |
| Interest-bearing Debt | ¥30,078M | ¥0M | - | - |
| Equity Ratio | 31.02% | 32.83% | 33.37% | 33.95% |
| D/E Ratio | 0.06 | 0.00 | 0.00 | 0.00 |
| Cash Flow | ||||
| Operating CF | ¥61,216M | ¥16,146M | ¥61,843M | ¥60,559M |
| Investing CF | -¥24,343M | -¥39,494M | -¥7,817M | -¥3,363M |
| Financing CF | -¥16,471M | -¥43,541M | -¥25,248M | -¥25,947M |
| Free CF | ¥42,339M | ¥2,642M | ¥42,448M | ¥48,128M |
| Efficiency | ||||
| ROE | 5.55% | 6.91% | 6.91% | 6.50% |
| ROA | 1.72% | 2.27% | 2.31% | 2.21% |
Latest IR Information
-
Q1 2027 Term Financial Summary (Japan GAAP) (Consolidated)
Sales of 989,503 hundred million yen, up 4.7% YoY; quarterly net income attributable to owners of parent of 13,646 hundred million yen, up 42.3% YoY. By segment, medical pharmaceuticals wholesale is strong, but overall operating income declines to 13,386 hundred...
Read more -
[Medipal HD] Dividend Revision|Fiscal Year Ending March 2027
Medipal HD has revised its dividend forecast for the fiscal year ending March 2027, increasing both the interim and year-end dividends by 10 yen to 44 yen each, with an expected total annual dividend of 88 yen.
Read more -
Full-year Earnings Forecast Revision | Medipal Holdings July 14, 2026
Medipal Holdings Corporation revised its full-year consolidated earnings forecast for the fiscal year ending March 2027, announced on May 14, 2026. Revenue remains unchanged at 3,944,000 hundred million yen, while net profit has been upwardly revised to 43,000 hundred million...
Read more -
[Medipal Holdings] Receipt of Dividends from Consolidated Subsidiaries | July 2026
Expected receipt of dividends totaling 42,100 million yen from 8 consolidated subsidiaries. This amount will be recorded as operating income in the standalone financial statements for the fiscal year ending March 2027 and will not impact consolidated results.
Read more -
Notice Regarding the Results of the Public Tender Offer for PALTAC Co., Ltd. (Securities Code: 8283)
Discloses the key figures such as amount, number of shares, and period. Tender offer price is 6,650 yen per share, planned tender volume 28,940,739 shares, period from 2026/05/12 to 2026/07/07, total tendered shares reaching 24,466,104, leading to decision to conduct...
Read more
Latest News (5 items)
-
Average Analyst Rating: hold
Average Target Price: ¥2,963
Rating Score: 3.25 (Based on 4 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprising medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; and animal health products for companion animals; and food processing raw materials for agriculture, fisheries, and livestock. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand; and distributes specialty pharmaceuticals. Further, the company is involved in contract logistics services; information provision services; health insurance claims review, medical coding dispatch, outsourcing and remote education; and creation of a medical supply database and master product databases for medical facilities. It serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fish producers, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.